株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

精密医療 (プレシジョンメディシン) の世界市場の予測:2019年〜2029年

Global Precision Medicine Market Forecast 2019-2029

発行 Visiongain Ltd 商品コード 632844
出版日 ページ情報 英文 212 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=138.94円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
精密医療 (プレシジョンメディシン) の世界市場の予測:2019年〜2029年 Global Precision Medicine Market Forecast 2019-2029
出版日: 2019年05月30日 ページ情報: 英文 212 Pages
概要

世界の精密医療 (プレシジョンメディシン) 市場は、2018年〜2029年のCAGR (複合年間成長率) で、10.5%の成長が見込まれています。

当レポートでは、世界の精密医療 (プレシジョンメディシン) 市場について調査分析し、市場概要、市場力学、市場予測、主要地域の予測、主要企業などについて、体系的な情報を提供しています。

第1章 レポート概要

第2章 精密医療 (プレシジョンメディシン) のイントロダクション

  • 精密医療の発展と略歴
  • 精密医療の主なメリット
  • 主な適応分野
  • 主な要素
  • さまざまなデータタイプ
  • 関心分野

第3章 世界の精密医療 (プレシジョンメディシン) 市場

  • エンドユーザー別
  • 技術別
  • 治療適応別
  • 地域別

第4章 市場力学

  • 市場促進要因
  • 市場抑制要因
  • 市場の機会
  • 規制機関
  • コンソーシアム
  • アライアンス/協会

第5章 世界の精密医療 (プレシジョンメディシン) 市場の予測:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオテクノロジー企業
  • 診断ツール企業
  • 医療用IT専門企業/ビッグデータ企業
  • 臨床検査室

第6章 世界の精密医療 (プレシジョンメディシン) 市場の予測:技術別

  • イントロダクション
  • コンパニオン診断
  • バイオマーカー
  • 標的療法
  • ファーマコゲノミクス (薬理ゲノム学)
  • 分子診断

第7章 世界の精密医療 (プレシジョンメディシン) 市場の予測:治療適応別

  • イントロダクション
  • がん
  • 心血管疾患 (CVD)
  • 中枢神経系 (CNS)
  • 感染症
  • 免疫学
  • その他

第8章 世界の精密医療 (プレシジョンメディシン) 市場の予測:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第9章 市場分析

  • ファイブフォース分析
  • バリューチェーン分析

第10章 企業プロファイル

  • Abbott Laboratories
  • GE Healthcare
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Pfizer Inc.
  • Laboratory Corporation of America Holdings
  • Danaher Corporation
  • QAGEN
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Novartis AG

第11章 競合情勢

図表

List of Tables

  • Table 2.1 Key Benefits of Precision Medicine
  • Table 2.2 Key Elements of Precision Medicine
  • Table 4.1 Key Benefits of Precision Medicine for Patients
  • Table 4.2 Key Laws & Regulatory Bodies in the Precision Medicine Industry
  • Table 4.3 Key Consortiums in the Precision Medicine Industry
  • Table 4.4 Key Alliances/Associations in the Precision Medicine Industry
  • Table 5.1 Global Precision Medicine Market Forecast by End-Users: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 5.2 Global Pharma & Biotech Companies End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 5.3 Key Developments in Pharma & Biotech Companies
  • Table 5.4 Global Diagnostic Tool Companies End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 5.5 Key Developments in Diagnostic Companies
  • Table 5.6 Global Healthcare ITs/Big Data End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 5.7 Key Developments in Healthcare IT/Big Data Companies
  • Table 5.8 Global Clinical Laboratories Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 6.1 Global Precision Medicine Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 6.2 Global Companion Diagnostics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 6.3 List of Approved Companion Diagnostic Devices
  • Table 6.4 Global Biomarkers Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 6.5 List of Biobanks
  • Table 6.6 Examples of Biobanking Initiatives Across Selected OECD Countries
  • Table 6.7 Global Biobanking in Targeted Therapeutics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 6.8 Global Pharmacogenomics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 6.9 Market Developments
  • Table 6.10 Global Molecular Diagnostics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 6.11 Some Examples of Human Genetic Tests That Have Been Approved by the FDA
  • Table 6.12 Some Examples of Microbial Tests That Have Been Approved by the FDA
  • Table 7.1 Global Precision Medicine Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 7.2 Global Cancer Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 7.3 Precision Medicine Drugs and Relevant Genes: Oncology
  • Table 7.4 Precision Medicine Genetic Tests with Respect to Oncology
  • Table 7.5 Key Developments
  • Table 7.6 Global Cardiovascular Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 7.7 Precision Medicine Drugs and Relevant Genes: Cardiovascular
  • Table 7.8 Precision Medicine Genetic Tests with Respect to Cardiovascular
  • Table 7.9 Key Developments
  • Table 7.10 Global CNS Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 7.11 Precision Medicine Drugs and Relevant Genes: Neurology
  • Table 7.12 Precision Medicine Drugs and Relevant Genes: Psychiatric Disorders
  • Table 7.13 Precision Medicine Genetic Tests with Respect to Psychiatric Disorders
  • Table 7.14 Psychiatric Disorders: Key Developments
  • Table 7.15 Global Infectious Disease Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 7.16 Precision Medicine Drugs and Relevant Genes: Infectious Diseases
  • Table 7.17 Key Developments
  • Table 7.18 Global Immunology Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 7.19 Global Other Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 7.20 Precision Medicine Drugs and Relevant Genes: Other Diseases
  • Table 7.21 Precision Medicine Genetic Tests with Respect to Other Diseases
  • Table 7.22 Key Developments
  • Table 8.1 Global Precision Medicine Market by Geography: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 8.2 North America Precision Medicine Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 8.3 Market Developments
  • Table 8.4 Europe Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 8.5 Market Developments
  • Table 8.6 APAC Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 8.7 Market Developments
  • Table 8.8 Middle East & Africa Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 8.9 Market Developments
  • Table 8.10 Latin America Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 8.11 Market Developments
  • Table 9.1 Key Factors Affecting the Bargaining Power of Suppliers
  • Table 9.2 Key Factors Affecting the Bargaining Power of Buyer
  • Table 9.3 Key Factors Affecting the Industry Rivalry
  • Table 9.4 Key Factors Affecting the Threat of New Entrants
  • Table 9.5 Key Factors Affecting the Threat of Substitutes
  • Table 10.1 Abbott Laboratories: Overview
  • Table 10.2 Abbott Laboratories: 5-year Revenue, Net Income, Operating Income ($ Mn)
  • Table 10.3 Abbott Laboratories: Key Developments
  • Table 10.4 GE Healthcare Overview
  • Table 10.5 GE Healthcare: 5-year Revenue, Profit ($ Mn)
  • Table 10.6 GE Healthcare: Key Developments
  • Table 10.7 GlaxoSmithKline plc: Overview
  • Table 10.8 GlaxoSmithKline plc: 5-year Revenue, Operating Profit, Profit After Tax ($ Mn)
  • Table 10.9 Johnson & Johnson: Overview
  • Table 10.10 Johnson & Johnson: 5-year Revenue, Net Earnings ($ Mn)
  • Table 10.11 Johnson & Johnson: Key Developments
  • Table 10.12 Pfizer Inc. Overview
  • Table 10.13 Pfizer Inc.: 5-year Revenue ($ Mn)
  • Table 10.14 Pfizer Inc: Key Developments
  • Table 10.15 Laboratory Corporation of America Holdings: Overview
  • Table 10.16 Laboratory Corporation of America Holdings: 5-year Revenue, Net Income, Operating Income ($ Mn)
  • Table 10.17 Laboratory Corporation: Key Developments
  • Table 10.18 Danaher Corporation: Overview
  • Table 10.19 Danaher Corporation: 5-year Revenue, Net Income, Operating Profit ($ Mn)
  • Table 10.20 Danaher Corporation: Key Developments
  • Table 10.21 QIAGEN: Overview
  • Table 10.22 QIAGEN: 5-year Revenue, Net Income ($ Mn)
  • Table 10.23 Thermo Fisher Scientific, Inc.: Overview
  • Table 10.24 Thermo Fisher Scientific, Inc.: 5-year Revenue, Net Income, Operating Income ($ Bn)
  • Table 10.25 Illumina, Inc.: Overview
  • Table 10.26 Illumina, Inc.: 5-year Revenue, Net Income, Operating Income ($bn)
  • Table 10.27 Novartis AG: Overview
  • Table 10.28 Novartis AG: 3-year Revenue, Net Income, Operating Income ($bn)
  • Table 11.1 Key Partnerships, Collaborations and Joint Ventures
  • Table 11.2 Key Product Developments
  • Table 11.3 Key Acquisitions
  • Table 11.4 Key Expansion
  • Table 11.5 Key Patents, Approvals and Certifications
  • Table 11.6 Key Other Events

List of Figures

  • Figure 1.1 Global Precision Medicine Market - Segmentation by Technology
  • Figure 1.2 Global Precision Medicine Market - Segmentation by End Users
  • Figure 1.3 Global Precision Medicine Market - Segmentation by Therapeutic Application
  • Figure 1.4 Global Precision Medicine Market - Segmentation by Geography
  • Figure 2.1 History of Precision Medicine
  • Figure 2.2 Key Areas of Application for Precision Medicine
  • Figure 2.3 Key Different Type of Data Used by Big Data Companies in Precision Medicine
  • Figure 2.4 Key Areas of Interest for Precision Medicine
  • Figure 3.1 Global Precision Medicine Market Share by End Users: Revenue ($bn), 2018-2029
  • Figure 3.2 Global Precision Medicine Market Size by Technology: Revenue ($bn), 2018-2029
  • Figure 3.3 Global Precision Medicine Market Size by Therapeutic Application: Revenue ($bn), 2018-2029
  • Figure 3.4 Global Precision Medicine Market Size by Geography: Revenue ($bn), 2019-2029
  • Figure 4.1 Key Difficulties Faced by Players of Precision Medicine Market due to Regulations and Standards
  • Figure 4.2 FDA's Role in Precision Medicine
  • Figure 5.1 Global Precision Medicine Market by End Users
  • Figure 5.2 Role of Pharmaceuticals and Biotech Companies
  • Figure 5.3 Challenges Faced by Pharma & Biotech Companies
  • Figure 5.4 Diagnostic Tests Benefits for Stakeholders
  • Figure 5.5 Challenges Faced by Diagnostic Companies
  • Figure 5.6 Benefits of Big Data
  • Figure 5.7 Transformation of Medicine
  • Figure 5.8 Basic Ingredients Provided by Big Data for Precision Medicine
  • Figure 5.9 Challenges Faced by Big Data Companies
  • Figure 5.10 OECD Recommendations on The Governance of Clinical Trials
  • Figure 6.1 Types of Precision Medicine Sub-Market
  • Figure 6.2 Benefits of Companion Diagnostics
  • Figure 6.3 Function of Biomarkers
  • Figure 6.4 Biobanks Services
  • Figure 6.5 Development in PGx
  • Figure 6.6 Model Systems Used in PGx
  • Figure 6.7 Challenges of PGx Studies
  • Figure 6.8 Type of Molecular Diagnostics Test
  • Figure 6.9 Molecular Diagnostics: Application
  • Figure 6.10 Molecular Diagnostics: Benefits
  • Figure 8.1 Global Precision Medicine Market Classification by Geography
  • Figure 8.2 Key Drivers for Precision Medicine: North America
  • Figure 8.3 Objectives of the Precision Medicine Initiative
  • Figure 8.4 APAC: Market Challenges
  • Figure 9.1 Precision Medicine Market Porter's Five Forces Analysis, 2018
  • Figure 9.2 Precision Medicine Market Value Chain
  • Figure 10.1 Abbott Laboratories: Sales by Business Segment (%), 2018
  • Figure 10.2 Abbott Laboratories: Sales by Region (%), 2018
  • Figure 10.3 GE Healthcare: Sales by Business Segment (%), 2017
  • Figure 10.4 GE Healthcare: Sales by Geography (%), 2017
  • Figure 10.5 GlaxoSmithKline plc: Sales by Business
  • Figure 10.6 GlaxoSmithKline plc: Sales by Region (%), 2017
  • Figure 10.7 Johnson & Johnson: Sales by Business Segment (%), 2017
  • Figure 10.8 Johnson & Johnson: Sales by Region (%), 2017
  • Figure 10.9 Pfizer Inc.: Sales by Business Segment (%), 2018
  • Figure 10.10 Pfizer Inc.: Sales by Region (%), 2018
  • Figure 10.11 Laboratory Corporation of America Holdings: Sales by Business Segment (%), 2017
  • Figure 10.12 Laboratory Corporation of America Holdings: Sales by Region (%), 2017
  • Figure 10.13 Danaher Corporation: Sales by Business Segment (%), 2017
  • Figure 10.14 Danaher Corporation: Sales by Region (%), 2017
  • Figure 10.15 QIAGEN: Sales by Business Segment (%), 2018
  • Figure 10.16 QIAGEN: Sales by Region (%), 2018
  • Figure 10.17 Thermofisher Scientific, Inc.: Sales by Business Segment (%), 2018
  • Figure 10.18 Thermofisher Scientific, Inc.: Sales by Region (%), 2018
  • Figure 10.19 Illumina, Inc.: Sales by Business Segment (%), 2017
  • Figure 10.20 Illumina, Inc.: Sales by Region (%), 2017
  • Figure 10.21 Novartis AG: Sales by Business Segment (%), 2018
  • Figure 10.22 Novartis AG: Sales by Region (%), 2018
  • Figure 11.1 Precision Medicine Market Key Development Strategies

Companies Listed

  • 23andMe
  • Abbott
  • Abbott Molecular Inc.
  • Abcodia
  • ACS Biomarker
  • Actelion Pharmaceuticals Ltd.
  • Advanced Biological Laboratories
  • Affymetrix, Inc.
  • Agendia BV
  • Alacer Corp
  • Alberta Cancer Research Biobank
  • Alios BioPharma, Inc.
  • Almac
  • Almac Diagnostics
  • Amgen
  • Apple
  • Archimedes
  • Aspen
  • Astellas Pharma Inc.
  • Astrazeneca plc
  • Astute Medical
  • Asuragen, Inc.
  • AT&T
  • AthenaHealth, Inc.
  • Aurora
  • Auspex Pharmaceuticals, Inc.
  • Avon Longitudinal Study of Parents and Children
  • BGI Tech Solutions Co., Ltd.
  • BioFortis
  • BioGene
  • bioMerieux, Inc.
  • Bode Technology Group, Inc.
  • CareWell Urgent Care
  • Caris
  • Celera Diagnostics
  • Cell & Co Biorepository
  • Celtics Healthcare
  • Cepheid
  • CFR Pharmaceuticals
  • Ciba-Geigy
  • Clarient Diagnostic Services, Inc.
  • Cognizant
  • Cooperative Human Tissue Network
  • COPAN
  • Covance Inc.
  • Cubist Pharmaceuticals
  • Daiichi Sankyo Co. ltd.
  • Dako
  • Dako Denmark A/S
  • Dell
  • Diabeter
  • Eagle Pharmaceuticals, Inc.
  • Eli Lilly
  • Estonian Genome Project
  • Ferring Pharmaceuticals
  • Fisher BioServices
  • Flakka
  • Foundation Medicine
  • GE Healthcare
  • Genome Medicine
  • Genomic Health
  • GenoSpace
  • Gen-Probe, Inc.
  • GlaxoSmithKline (GSK)
  • Glooko
  • Google Inc.
  • Hologic, Inc.
  • Human Tissue Resource Network
  • HUNT Biobank
  • IBM
  • Idera Pharmaceuticals Inc.
  • Illumina, Inc.
  • Immuneering Corporation
  • Infectio Diagnostic, Inc.
  • Institutional Biobank of Lausanne
  • Intel
  • Intomics
  • Janssen Biotech Inc.
  • Japan Post Group
  • Johnson & Johnson
  • Kaiser Permanente
  • Lab-Ally LLC
  • Laboratory Corporation of America
  • LG
  • Life Technologies
  • llumina Inc.
  • Luminex Molecular Diagnostics Inc.
  • Lutron Electronics
  • Mayo Clinic
  • Medpace
  • Medtronic
  • Medtronic plc
  • Merck
  • Modul-Bio
  • Molecular Health
  • Monogram Bioscience
  • Myriad Genetic Laboratories, Inc.
  • Nanosphere, Inc.
  • NanoString
  • NextWave
  • Novartis
  • Omnyx, LLC
  • OncoMed Pharmaceuticals, Inc.
  • Oncotype DX
  • OneMedNet Corporation
  • Oracle Healthcare
  • Panasonic Healthcare
  • PATH Biobank
  • Pfizer
  • Philips Healthcare
  • ProMedDx
  • Q2 Solutions
  • Qiagen
  • Qiagen Manchester, Ltd.
  • Qualcomm
  • Qualcomm Life, Inc.
  • Quest Diagnostics
  • Randox Laboratories
  • Randox Toxicology
  • Reddy Laboratories
  • Roche
  • Roche Molecular Systems, Inc.
  • Royal Philips
  • Samsung
  • Sandoz
  • Sanofi Aventis
  • Sanofi Pharma
  • Siemens Clinical Lab
  • Siemens Healthcare
  • Signature Diagnostics AG
  • St. Jude Medical (SJM)
  • Sterand Plc
  • Syapse
  • Sysmex
  • Sysmex Corporation
  • Takeda Pharmaceuticals
  • Teva Pharmaceuticals
  • Therascreen
  • Topera, Inc
  • Trofile
  • U.K. Biobank
  • UMass Cancer Center Tissue and Tumor Bank
  • Ventana Medical Systems, Inc.
  • Veropharm
  • Vysis
  • Zinfandel Pharmaceuticals

List of Organizations Mentioned in the Report

  • Alberta Health Services
  • Alberta Tumour Bank
  • American Association for Cancer Research (AACR)
  • American Medical Association
  • American National Standards Institute (ANSI)
  • American Telemedicine Association
  • Association for Molecular Pathology
  • Beth Israel Deaconess Medical Center (BIDMC)
  • Biobank Japan-Riken Institute
  • Biobanque de Picardie
  • Biological Resources Centres
  • Canadian Biosample Repository
  • Canadian Federal Government
  • Canadian Institutes of Health Research (CIHR)
  • Cancer Research Network of the FRSQ
  • Capital Health/Regional Tissue Bank
  • Careggi University Hospital
  • Central Biomaterial Bank
  • Centre for Disease Control and Prevention (CDC)
  • Charité-Universitétsmedizin Berlin
  • Confederation of Cancer Biobanks
  • Danubian Biobank Consortium Tissue Bank
  • Drug Enforcement Agency (DEA)
  • European Association for Cancer Research (EACR)
  • European Diagnostics Manufacturers Association (EDMA)
  • European Federation of Pharmaceutical Industries and Associations (EFPIA)
  • European Medicines Agency (EMA)
  • European Society of Human Genetics
  • Food and Drug Administration (FDA)
  • Genethon DNA and Cell Bank
  • German Heart Failure Network
  • Global Medical Technology Alliance (GMTA)
  • Health Science Research Resources Bank/Japan Health Science Foundation
  • Healthcare information and management systems society (HIMSS)
  • International Human Genome Sequencing Consortium
  • International Medical Device Regulators Forum (IMDRF)
  • Japan National Cancer Center Brain Bank for Aging Research
  • Japanese Collection of Research Bioresources
  • King's College Infectious Diseases Biobank
  • Liverpool Tissue Bank
  • Manitoba Breast Tumour Bank
  • National Institutes of Health (NIH)
  • NHS Cod Blood Bank
  • Norwegian University of Science and Technology
  • Office of the national coordinator for health information technology (ONC HIT)
  • Ohio State University
  • Ontario Cancer Research Network
  • Organization of European Cancer Institute (OECI)
  • Patient DNA collection at Institute of Human Genetics Heidelberg
  • Patient-Centered Outcomes Research Institute (PCORI)
  • Pharmaceutical and medical devices agency (PMDA)
  • PROCURE Quebec Prostate Cancer
  • Southwest France Tumour Bank
  • The Brain Tumour Tissue Bank
  • The Center for Assessment Technology and Continuous Health (CATCH)
  • The National Center for Toxicological Research (NCTR)
  • The National Health Services (NHS)
  • The National Institute for Health Research (NIHR)
  • Therapeutic Goods Administration (TGA)
  • Triangle Global Health Consortium
  • Tumour Bank of Provence
  • U.K. Biobank Roslin Wellcome Trust Tick Cell Biobank
  • U.K. DNA Banking Network
  • U.K. Stem Cell Bank
  • United Kingdom Clinical Research Network (UKCRN)
  • University Hospital of Lausanne and University of Lausanne
  • University of Bristol
  • University of Massachusetts Medical School
  • University of Tartu
  • Wireless-Life Sciences Alliance (WLSA)
  • World Health Organisation (WHO)
目次
Product Code: PHA0424

The global precision medicine market is expected to grow at an estimated CAGR of 10.5% from 2018 to 2029. In the precision medicine market, the Diagnostic Tool companies' segment is dominating the global market and accounted for $23.36 billion in 2018 due to the development of large number of diagnostic and genetic tests.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 212-page report you will receive 98 tables and 63 figures - all unavailable elsewhere.

The 212-page report provides clear detailed insight into the global precision medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

  • Global Precision Medicine Market forecasts from 2019-2029
  • Along with revenue prediction for the overall market for the global precision medicine market, our investigation shows forecasts to 2029 for the market segmented by technology :
    • Companion Diagnostics
    • Biomarker-based Test
    • Targeted Therapeutics
    • Pharmacogenomics
    • Molecular Diagnostics

The report discusses key trends, developments and participants .

  • This report breaks down the precision medicine market forecast to 2029 by end-users :
    • Pharmaceuticals & Biotechnology Companies
    • Diagnostic Companies
    • Healthcare IT/Big Data Companies
    • Clinical Laboratories

The report discusses key trends, developments and participants.

  • This report also breaks down the precision medicine market forecast to 2029 by therapeutic application :
    • Cancer
    • Cardiovascular Diseases
    • Central Nervous System
    • Infectious Diseases
    • Immunology
    • Others

The report discusses key trends, developments and participants .

  • This study provides precision medicine market forecasts to 2029 for these regional markets :
    • North America: US & Canada
    • Europe: Germany, UK, France, Italy, Spain, Rest of Europe
    • Asia-Pacific: China, japan, India, Australia, South Korea, Rest of Asia-Pacific
    • Middle East & Africa: South Africa, Saudi Arabia, Rest of Middle East & Africa
    • Latin America: Brazil, Mexico, Rest of Latin America

For each regional market, the report discusses key trends, developments and participants .

  • This report profiles selected leading companies that are the main players in the global precision medicine market:
    • Abbott
    • Danaher Corporation
    • GE Healthcare
    • GlaxoSmithKline
    • Illumina, Inc.
    • Johnson & Johnson
    • Laboratory Corporation of America Holdings
    • Novartis
    • Pfizer
    • QIAGEN
    • Thermo Fisher Scientific, Inc.

image1

  • Our study discusses the drivers, restraints as well as the opportunities in the global precision medicine market.
  • This study also analyzed the global precision medicine market with Porter's Five Forces Analysis as well as Value Chain Analysis
  • This report discusses selected market developments in the precision medicine market: partnership, collaboration, join venture, acquisitions, product launch, product development, expansions, patents, approvals .

Visiongain's study is intended for anyone requiring commercial analyses for the global precision medicine market. You find data, trends and predictions.

Buy our report today Global Precision Medicine Market Forecast 2019-2029: Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases.

Table of Contents

1. Report Overview

  • 1.1 Global Precision Medicine Market Overview
    • 1.1.1 Precision Medicine Market - Segmentation by Technology
    • 1.1.2 Precision Medicine Market - Segmentation by End Users
    • 1.1.3 Precision Medicine Market - Segmentation by Therapeutic Application
    • 1.1.4 Precision Medicine Market - Segmentation by Geography
  • 1.2 Why You Should Read This Report
  • 1.3 How This Report Delivers
  • 1.4 Key Questions Answered by This Analytical Report Include
  • 1.5 Who is This Report For?
  • 1.6 Methodology
    • 1.6.1 Primary Research
    • 1.6.2 Secondary Research
    • 1.6.3 Market Evaluation & Forecasting Methodology
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2. Introduction to Precision Medicine

  • 2.1 Evolution and Brief History of Precision Medicine
  • 2.2 Key Benefits of Precision Medicine
  • 2.3 Precision Medicine: Key Areas of Application
  • 2.4 Precision Medicine: Key Elements
  • 2.5 Precision Medicine: Different Type of Data Used by Big Data Companies
  • 2.6 Precision Medicine: Area of Interest

3. Global Precision Medicine Market 2019-2029

  • 3.1 Global Precision Medicine Market by End-Users, 2019-2029
  • 3.2 Global Precision Medicine Market by Technology, 2019-2029
  • 3.3 Global Precision Medicine Market by Therapeutic Application, 2019-2029
  • 3.4 Global Precision Medicine Market by Geography, 2019-2029

4. Market Dynamics

  • 4.1 Global Precision Medicine Market Drivers
    • 4.1.1 Upcoming Technologies in Healthcare
    • 4.1.2 Collaboration of Big Data Companies with Pharma & Biotech Companies
    • 4.1.3 Greater Involvement in Personal Healthcare
    • 4.1.4 A Rise in Genetic Diseases
    • 4.1.5 Growing Demand for Targeted Therapies
  • 4.2 Global Precision Medicine Market Restraints
    • 4.2.1 Limitations in Application due to Lack of Research and Evidences
    • 4.2.2 Stringent Regulatory Framework and Reimbursement Policies
    • 4.2.3 Stringent Regulations and Standards
    • 4.2.4 Higher Cost of Diagnostics
    • 4.2.5 Risk to Personal Data
    • 4.2.6 Risk of failure of Software or Hardware
    • 4.2.7 Lack of Knowledge and Awareness
  • 4.3 Global Precision Medicine Market Opportunities
    • 4.3.1 Increasing Awareness in Developing Economies
    • 4.3.2 Reduction in the cost of Genome Sequencing
  • 4.4 Regulatory Bodies
    • 4.4.1 Food and Drug Administration (FDA)
    • 4.4.2 Medicines and Healthcare Products Regulatory Agency (MHRA)
    • 4.4.3 Therapeutic Goods Administration (TGA)-Australia
    • 4.4.4 Conformité Européenne (CE)
  • 4.5 Consortiums
  • 4.6 Alliances/Associations

5. Global Precision Medicine Market Forecast 2019-2029 - Segmented by End-Users

  • 5.1 Introduction
    • 5.1.1 Global Precision Medicine Market Forecast 2019-2029: Segmented by End-Users
  • 5.2 Global Pharmaceuticals and Biotechnology Companies Submarket Forecast 2019-2029
    • 5.2.1 Key Market Trends, Developments and Participants
      • 5.2.1.1 Market Trends
      • 5.2.1.2 Market Developments
      • 5.2.1.3 Key Participants
  • 5.3 Global Diagnostic Tools Companies Submarket Forecast 2019-2029
    • 5.3.1 Key Market Trends, Developments and Participants
      • 5.3.1.1 Market Trends
      • 5.3.1.2 Market Developments
      • 5.3.1.3 Key Participants
  • 5.4 Global Healthcare IT Specialists/ Big Data Companies Submarket Forecast 2019-2029
    • 5.4.1 Key Market Trends, Developments and Participants
      • 5.4.1.1 Market Trends
      • 5.4.1.2 Market Developments
      • 5.4.1.3 Key Participants
  • 5.5 Global Clinical Laboratories Submarket Forecast 2019-2029
    • 5.5.1 Key Market Trends, Developments and Participants
      • 5.5.1.1 Regulatory bodies and compliances
      • 5.5.1.2 Market Trends
      • 5.5.1.3 Key Participants

6. Global Precision Medicine Market Forecast 2019-2029 - Segmented by Technology

  • 6.1 Introduction
    • 6.1.1 Global Precision Medicine Market Forecast 2019-2029: Segmented by Technology
  • 6.2 Global Companion Diagnostics Submarket Forecast 2019-2029
  • 6.3 Global Biomarkers Submarket Forecast 2019-2029
    • 6.3.1 Role of Biobanking in Biomarker
    • 6.3.2 Key Participants
  • 6.4 Global Biobanking in Targeted Therapeutics Submarket Forecast 2019-2029
    • 6.4.1 Key Participants
  • 6.5 Global Pharmacogenomics Submarket Forecast 2019-2029
    • 6.5.1 Key Market Trends, Developments and Participants
      • 6.5.1.1 Market Trends
      • 6.5.1.2 Market Developments
      • 6.5.1.3 Key Participants
  • 6.6 Global Molecular Diagnostics Submarket Forecast 2019-2029

7. Global Precision Medicine Market Forecast 2019-2029: Segmented by Therapeutic Application

  • 7.1 Introduction
    • 7.1.1 Global Precision Medicine Market Forecast 2019-2029: Segmented by Therapeutic Application
  • 7.2 Global Cancer Submarket Forecast 2019-2029
    • 7.2.1 Types of Cancer
    • 7.2.2 Key Market Trends, Developments & Participants
      • 7.2.2.1 Market Trends
      • 7.2.2.2 Market Developments
      • 7.2.2.3 Key Participants
  • 7.3 Global Cardiovascular Disease (CVD) Submarket Forecast 2019-2029
    • 7.3.1 Drugs & Tests
    • 7.3.2 Market Trends & Market Developments
      • 7.3.2.1 Market Trends
      • 7.3.2.2 Market Developments
      • 7.3.2.3 Key Participants
  • 7.4 Global Central Nervous System (CNS) Market Forecast 2019-2029
    • 7.4.1 Neurological
      • 7.4.1.1 Neurological Drugs & Tests
    • 7.4.2 Psychiatric Disorders
      • 7.4.2.1 Psychiatric Disorder Drugs & Tests
    • 7.4.3 Market Trends & Market Developments
      • 7.4.3.1 Market Trends
      • 7.4.3.2 Key Participants
  • 7.5 Global Infectious Diseases Submarket Forecast 2019-2029
    • 7.5.1 Infectious Diseases Drugs & Tests
    • 7.5.2 Market Developments & participants
      • 7.5.2.1 Key Developments
      • 7.5.2.2 Key Participants
  • 7.6 Global Immunology Market Forecast 2019-2029
    • 7.6.1 Market Trends
      • 7.6.1.1 Market Trends
  • 7.7 Global Other Therapeutic Application Submarket Forecast 2019-2029
    • 7.7.1 Market Trends, Developments & Participants
      • 7.7.1.1 Market Trends
      • 7.7.1.2 Key Developments
      • 7.7.1.3 Key Participants

8 Global Precision Medicine Market Forecast 2019-2029 - Segmented by Geography

  • 8.1 Introduction
  • 8.2 North America Precision Medicine Market Forecast 2019-2029
    • 8.2.1 U.S.
      • 8.2.1.2 Canada
      • 8.2.1.3 Key Market Trends, Developments and Participants
        • 8.2.1.3.1 Regulations and Compliances
        • 8.2.1.3.2 Market Trends
        • 8.2.1.3.3 Market Developments
      • 8.2.1.4 Key Participants
  • 8.3 Europe Precision Medicine Market Forecast 2019-2029
    • 8.3.1 Key Market Trends, Developments and Participants
      • 8.3.1.1 Regulations and Compliances
      • 8.3.1.2 Market Developments
      • 8.3.1.3 Key Participants
  • 8.4 Asia-Pacific (APAC) Precision Medicine Market Forecast 2019-2029
    • 8.4.1 Key Market Trends, Developments and Participants
      • 8.4.1.1 Market Developments
      • 8.4.1.2 Key Participants
  • 8.5 Middle East & Africa Precision Medicine Market Forecast 2019-2029
    • 8.5.1 Key Market Developments and Participants
      • 8.5.1.1 Market Developments
      • 8.5.1.2 Key Participants
  • 8.6 Latin America Precision Medicine Market Forecast 2019-2029
    • 8.6.1 Key Market Developments and Participants
      • 8.6.1.1 Market Developments
      • 8.6.1.2 Key Participants

9. Market Analysis

  • 9.1 Porter's Five Forces Analysis
    • 9.1.1 Bargaining Power of Suppliers
    • 9.1.2 Bargaining Power of Buyer
    • 9.1.3 Industry Rivalry
    • 9.1.4 Threat of New Entrants
    • 9.1.5 Threat of Substitutes
  • 9.2 Value Chain Analysis
    • 9.2.1 Device Manufacturer & Drug Producers
    • 9.2.2 Healthcare Providers
    • 9.2.3 Healthcare IT Or Big Data Companies
    • 9.2.4 Regulators
    • 9.2.5 Third Party Payers
    • 9.2.6 Patients

10. Company Profiles

  • 10.1 Abbott Laboratories: Overview
    • 10.1.1 Abbott Laboratories: Products & Service
    • 10.1.2 Abbott Laboratories: Key Developments
    • 10.1.3 Abbott Laboratories: Future Outlook and Growth Strategy
  • 10.2 GE Healthcare: Overview
    • 10.2.1 GE Healthcare: Products & Service
    • 10.2.2 GE Healthcare: Key Developments
    • 10.2.3 GE Healthcare: Future Outlook and Growth Strategy
  • 10.3 GlaxoSmithKline plc: Overview
    • 10.3.1 GlaxoSmithKline plc: Products & Service
    • 10.3.2 GlaxoSmithKline plc: Future Outlook and Growth Strategy
  • 10.4 Johnson & Johnson: Overview
    • 10.4.1 Johnson & Johnson: Products & Service
    • 10.4.2 Johnson & Johnson: Key Developments
    • 10.4.3 Johnson & Johnson: Future Outlook and Growth Strategy
  • 10.5 Pfizer Inc.: Overview
    • 10.5.1 Pfizer Inc.: Products & Service
    • 10.5.2 Pfizer Inc.: Key Developments
    • 10.5.3 Pfizer Inc.: Future Outlook and Growth Strategy
  • 10.6 Laboratory Corporation of America Holdings Overview
    • 10.6.1 Laboratory Corporation of America Holdings: Products & Service
    • 10.6.2 Laboratory Corporation of America Holdings: Key Developments
  • 10.7 Danaher Corporation: Overview
    • 10.7.1 Danaher Corporation: Products & Service
    • 10.7.2 Danaher Corporation: Key Developments
  • 10.8 QAGEN: Overview
    • 10.8.1 QIAGEN: Products & Service
  • 10.9 Thermo Fisher Scientific, Inc.: Overview
    • 10.9.1 Thermo Fisher Scientific: Products & Service & Recent Developments
  • 10.10 Illumina, Inc.: Overview
    • 10.10.1 Illumina, Inc.: Products & Service & Recent Developments
  • 10.11 Novartis AG: Overview
    • 10.11.1 Novartis AG: Recent Developments

11. Competitive Landscape

  • 11.1 Introduction
    • 11.1.1 Partnerships, Collaborations and Joint Ventures
    • 11.1.2 Product Launch/Development
    • 11.1.3 Acquisitions
    • 11.1.4 Expansion
    • 11.1.5 Patents, Approvals and Certifications
    • 11.1.6 Others

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain Report Evaluation Form
Back to Top